TY - JOUR
T1 - Outreach for Annual Colorectal Cancer Screening
T2 - A Budget Impact Analysis for Community Health Centers
AU - Liss, David T.
AU - French, Dustin D.
AU - Buchanan, David R.
AU - Brown, Tiffany
AU - Magner, Bridget G.
AU - Kollar, Stephanie
AU - Baker, David W.
N1 - Publisher Copyright:
© 2016 American Journal of Preventive Medicine.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Introduction Fecal immunochemical testing (FIT) is an attractive approach for colorectal cancer screening at community health centers. This budget impact analysis investigated benefits and costs of FIT outreach - with FIT kits mailed to patients, followed by reminders and phone calls - compared with point-of-care (POC) strategies. Methods Five screening and cost outcomes were simulated over 1 year at a "base case" community health center serving 1000 screening-eligible patients: (1) FIT completion among patients due for screening; (2) proportion up-to-date on screening; (3) cost per patient due for screening; (4) cost per completed FIT; and (5) total organizational cost. Uncertainty analysis investigated potential savings from optimizing staff workflows during FIT outreach. Data were collected in 2012-2014, with analysis conducted 2014-2015. Results Using POC strategies, 24.0% of patients due for screening completed FIT, versus 42.4% under outreach (18.4% absolute difference). When calculations included patients up-to-date on screening from prior colonoscopy, 41.7% were up-to-date via POC, versus 55.8% for outreach (14.1% absolute difference). POC cost $4.93 per patient, versus $30.43 for outreach ($25.50 difference). Cost per patient screened was $20.60 for POC and $71.84 for outreach ($51.24 difference). Total organizational cost was $3,779 for POC distribution and $23,315 for outreach ($19,536 difference). Outreach costs decreased by approximately one fourth under optimized workflows. Conclusions Outreach is an effective, practical, relatively low-cost strategy; costs could be reduced further by optimizing staff workflows. Despite its value, outreach costs more than POC distribution and may be difficult for community health centers to implement under current payment models.
AB - Introduction Fecal immunochemical testing (FIT) is an attractive approach for colorectal cancer screening at community health centers. This budget impact analysis investigated benefits and costs of FIT outreach - with FIT kits mailed to patients, followed by reminders and phone calls - compared with point-of-care (POC) strategies. Methods Five screening and cost outcomes were simulated over 1 year at a "base case" community health center serving 1000 screening-eligible patients: (1) FIT completion among patients due for screening; (2) proportion up-to-date on screening; (3) cost per patient due for screening; (4) cost per completed FIT; and (5) total organizational cost. Uncertainty analysis investigated potential savings from optimizing staff workflows during FIT outreach. Data were collected in 2012-2014, with analysis conducted 2014-2015. Results Using POC strategies, 24.0% of patients due for screening completed FIT, versus 42.4% under outreach (18.4% absolute difference). When calculations included patients up-to-date on screening from prior colonoscopy, 41.7% were up-to-date via POC, versus 55.8% for outreach (14.1% absolute difference). POC cost $4.93 per patient, versus $30.43 for outreach ($25.50 difference). Cost per patient screened was $20.60 for POC and $71.84 for outreach ($51.24 difference). Total organizational cost was $3,779 for POC distribution and $23,315 for outreach ($19,536 difference). Outreach costs decreased by approximately one fourth under optimized workflows. Conclusions Outreach is an effective, practical, relatively low-cost strategy; costs could be reduced further by optimizing staff workflows. Despite its value, outreach costs more than POC distribution and may be difficult for community health centers to implement under current payment models.
UR - http://www.scopus.com/inward/record.url?scp=84959450867&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959450867&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2015.07.003
DO - 10.1016/j.amepre.2015.07.003
M3 - Article
C2 - 26362405
AN - SCOPUS:84959450867
SN - 0749-3797
VL - 50
SP - e54-e61
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
IS - 2
ER -